Investment
Features
FeesSafety
Academy
More
Pluang+

Compare nVent Electric (NVT) vs Zoetis Inc (ZTS) Price & Performance

nVent ElectricTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

nVent Electric vs Zoetis Inc — how do they compare? nVent Electric trades at $158.56 (market cap $26.31B), while Zoetis Inc trades at $73.91 (market cap $30.40B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.88%). Which is the better fit depends on your goals.

NVTZTS
Market Cap
$26.31B$30.40B
Sector
IndustrialsHealth
52-Week High
$184.34$150.61
52-Week Low
$94.78$71.91
Enterprise Value
$27.69B$37.96B
Dividend Yield
0.52%2.88%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

nVent Electric

No Aura AI signal available yet.

Zoetis Inc

Zoetis (ZTS) trades at $73.60, down 2.92% amid bearish technical signals and mixed earnings. The stock faces pressure from weakening U.S. companion animal sales and competitive headwinds, though profitability remains strong with 71.67% gross margins and 27.69% net income margin. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a guidance cut. Analyst consensus is divided with 45% Buy ratings and a $93.40 price target, suggesting 27% upside from current levels.

The outlook balances valuation appeal (P/E of 12) against near-term operational challenges. Investment opportunity lies in market dominance and robust cash flow generation, while risks include sustained pet health demand softness and competitive pricing pressure. The stock trades near support at $73, with institutional sentiment mixed amid recent portfolio adjustments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About nVent Electric

nVent provides electrical connection and protection solutions, including enclosures, fastening systems, and thermal management products. Its products help support electrical and industrial infrastructure across multiple end markets.

Read more on NVT

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS